Heidelberg Pharma ( ETR:HPHA ) Third Quarter 2024 Results Key Financial Results Revenue: €3.56m (up 59% from 3Q 2023...
Key Insights Insiders appear to have a vested interest in Heidelberg Pharma's growth, as seen by their sizeable...